Terumo | 4543 - Selling And Administration Expenses


Terumo reported JPY114.81B in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Astellas Pharma JPY 234.7B 12.92B Mar/2026
Chugai Pharma JPY 28.9B 8.02B Mar/2026
Daiichi Sankyo JPY 228.23B 39.15B Dec/2025
Eisai JPY 119.54B 7.82B Mar/2026
Kyowa Hakko Kirin JPY 41.07B 2.82B Mar/2026
M3 JPY 26.84B 349M Mar/2026
Olympus JPY 139.34B 13.69B Mar/2026
Otsuka Holdings JPY 259.49B 18.81B Mar/2026
Shionogi JPY 38.04B 2.56B Mar/2026
Sumitomo Dainippon JPY 43.06B 2.16B Mar/2026
Takeda JPY 292B 9.21B Mar/2026
Terumo JPY 114.81B 9.55B Mar/2026